Banner - Collaborative Care Symposium

News
Media
Conferences
Events
Publications
CME
Partners
Subscribe
Resources

Conference Coverage

about 5 hours ago

aao

Reflections from the floor: AAO memories that shaped careers

28 days ago

aao

AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia

29 days ago

aao

AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined

about 1 month ago

aao

AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision

about 1 month ago

aao

AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives

about 1 month ago

aao

AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care

about 1 month ago

aao

AAO 2025: The rise of presbyopia research

about 1 month ago

aao

AAO 2025: The value of RGB imaging in OCT

about 1 month ago

aao

AAO 2025: Innovations in surgical visualization and imaging

about 1 month ago

aao

AAO 2025: Effect of cryopreserved amniotic membrane after corneal cross-linking in patients with keratoconus

Latest News

(Image credit: Ophthalmology Times) Reflections from the floor: AAO memories that shaped careers

Dec 27, 2025 | Commentary

Reflections from the floor: AAO memories that shaped careers

$(Image credit: AdobeStock/Антон Сальников) Refractory dry eye care: How systemic conditions change the game$

Refractory dry eye care: How systemic conditions change the game

The year in optometry: 10 stories that defined eye care in 2025

The year in optometry: 10 stories that defined eye care in 2025

(Image credit: AdobeStock/Ekaterina) Surgeon reflection: What patient case stayed with you in 2025?

Surgeon reflection: What patient case stayed with you in 2025?

Molecular insights and clinical experience: Extending anti-VEGF durability

Molecular insights and clinical experience: Extending anti-VEGF durability

(Image credit: Ophthalmology Times) Reflections from the floor: AAO memories that shaped careers

Reflections from the floor: AAO memories that shaped careers

4 experts are featured in this series.

Adopting Emerging Therapies in Dry Eye Care

Key Clinical Takeaways From Case-Based Discussions on Advanced IOL Selection

Key Clinical Takeaways From Case-Based Discussions on Advanced IOL Selection

IOL Selection and Expectation Management in a Hyperopic Patient With Astigmatism Considering Advanced Lenses

IOL Selection and Expectation Management in a Hyperopic Patient With Astigmatism Considering Advanced Lenses

3 experts are featured in this series.

Evaluating Retinal Drying, Durability and IOP Management with Second-Generation Anti-VEGF Therapies in Retinal Vascular Diseases

IOL Selection Using a Light Adjustable Lens in a Post-LASIK Painter With Color Sensitivity

IOL Selection Using a Light Adjustable Lens in a Post-LASIK Painter With Color Sensitivity

3 experts are featured in this series.

Loading Dose Adjustments and Treatment Switching Strategies in Retinal Vascular Diseases

Advanced IOL Selection in a Low Night-Driving Patient With Bilateral Cataracts

Advanced IOL Selection in a Low Night-Driving Patient With Bilateral Cataracts

Shorts

View All Shorts

Ophthalmology without OCT - Part 5

Ophthalmology without OCT - Part 5

a month ago

by

David A. Eichenbaum, MD, FASRS(+2 more)

Ophthalmology without OCT - Part 4

Ophthalmology without OCT - Part 4

a month ago

by

Nimesh Patel, MD(+3 more)

Ophthalmology without OCT - Part 3

Ophthalmology without OCT - Part 3

a month ago

by

Michael Lai, MD, PhD(+2 more)

Ophthalmology without OCT - Part 2

Ophthalmology without OCT - Part 2

a month ago

by

Justis P. Ehlers, MD(+2 more)

Ophthalmology without OCT

Ophthalmology without OCT

2 months ago

by

Andrew J. Barkmeier, MD(+3 more)

Most impactful discoveries in 5 decades - Part 6

Most impactful discoveries in 5 decades - Part 6

3 months ago

by

Martin David Harp

Most impactful discoveries in 5 decades - Part 5

Most impactful discoveries in 5 decades - Part 5

3 months ago

by

Martin David Harp

Most impactful discoveries in 5 decades - Part 4

Most impactful discoveries in 5 decades - Part 4

3 months ago

by

Martin David Harp

Most impactful discoveries in 5 decades - Part 3

Most impactful discoveries in 5 decades - Part 3

3 months ago

by

Martin David Harp

Most impactful discoveries in 5 decades - Part 2

Most impactful discoveries in 5 decades - Part 2

3 months ago

by

Martin David Harp

Ophthalmology Times Digital Edition

Molecular insights and clinical experience: Extending anti-VEGF durability

December 26th, 2025

Molecular insights and clinical experience: Extending anti-VEGF durability

Strategies for treatment intervals, drug selection, and patient expectations.

Reimagining dry eye care: Focus on sustained tear production

December 23rd, 2025

Reimagining dry eye care: Focus on sustained tear production

Panel examines drug mechanisms, patient factors, and strategies to optimize results.

From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases

December 22nd, 2025

From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases

Screening for Demodex blepharitis: Integrating best practices into routine eye care

December 19th, 2025

Screening for Demodex blepharitis: Integrating best practices into routine eye care

Seeing the difference: Multimodal imaging for AMD and GA

December 18th, 2025

Seeing the difference: Multimodal imaging for AMD and GA

This approach helps distinguish diseases associated with macular atrophy.

Malar edema: Perspectives from plastic surgery and ophthalmology

December 17th, 2025

Malar edema: Perspectives from plastic surgery and ophthalmology

Insights for diagnosing and managing these visible changes across specialties.

Spotlight on women's health: Understanding thyroid eye disease

December 17th, 2025

Spotlight on women's health: Understanding thyroid eye disease

Managing challenging pterygium removal: Amniotic membrane grafting strategies

December 16th, 2025

Managing challenging pterygium removal: Amniotic membrane grafting strategies

Tips for optimizing surgical techniques to reduce recurrence and enhance outcomes.

Strategic approaches optimize teaching and learning in the clinic

December 15th, 2025

Strategic approaches optimize teaching and learning in the clinic

Pre and postclinic routines, time blocking, and the Eisenhower Decision Matrix enhance efficiency in clinical education.

Monitoring MacTel: Why BCVA does not tell the whole story

December 10th, 2025

Monitoring MacTel: Why BCVA does not tell the whole story

Combining imaging and patient symptoms improves assessment of disease progression.

Podcasts

Glaucoma 2026: Which emerging technologies will change practice?

December 26, 2025

Glaucoma 2026: Which emerging technologies will change practice?

3 Things You Should Know About the GA Pipeline

December 23, 2025

The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

3 Things You Should Know About the GA Pipeline

December 23, 2025

Customized Clarity: Navigating IOL Options for Optimal Patient Care

(Image credit: Ophthalmology Times) Cinema as advocacy: The eye health message behind "My Eyes"

November 6, 2025

Cinema as advocacy: The eye health message behind "My Eyes"

(Image credit: Ophthalmology Times) Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists

November 6, 2025

Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists

Continuing Medical Education

EnVision Summit

In-Person Event

EnVision Summit

February 13-16, 2026

(CME Track) Patient-Centered Treatment Strategies in the Management of nAMD and DME

(CME Track) Patient-Centered Treatment Strategies in the Management of nAMD and DME

Adrienne W. Scott, MD, FASRS; Justine Cheng, MD; Hong-Uyen Hua, MD; Sherrol A. Reynolds OD, FAAO, FNAP

Practical Approaches to Modern Dry Eye Treatment and Management

Practical Approaches to Modern Dry Eye Treatment and Management

Marc R. Bloomenstein, OD, FAAO; Cory J. Lappin, OD, MS, FAAO; Selina R. McGee, OD, FAAO

(CME Track) Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments

(CME Track) Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments

David S. Liao, MD, PhD; Chang Sup Lee, MD; Douglas Matsunaga, MD; Daniel Su, MD

(CME Credit) Time Matters in GA: The Impact of Early Detection and Proactive Treatment Approaches

(CME Credit) Time Matters in GA: The Impact of Early Detection and Proactive Treatment Approaches

Laxmi V. Devisetty, MD; Rodney P. Coe, MD, MS; Majda Hadziahmetovic, MD; Xiao Yi (Ellie) Zhou, MD

(CME Track) Expanding Horizons in Toric IOLs: Translating Technological Advances Into Improved Patient Outcomes

(CME Track) Expanding Horizons in Toric IOLs: Translating Technological Advances Into Improved Patient Outcomes

Rahul Tonk, MD, MBA

(CME Track) The TED Perspective: A Multidisciplinary Approach to Thyroid Eye Care

(CME Track) The TED Perspective: A Multidisciplinary Approach to Thyroid Eye Care

Sara T. Wester, MD, FACS; Cecelia Koetting, OD; Sophie Liao, MD; Jennifer Murdock, MD

(CME Track) Visionary Approaches: Rethinking Therapeutic and Interventional Glaucoma Management

(CME Track) Visionary Approaches: Rethinking Therapeutic and Interventional Glaucoma Management

Rachel Simpson, MD; James Murphy, MD; Mary Qiu, MD; Jessica Steen, OD, FAAO

(COPE Track) Visionary Approaches: Rethinking Therapeutic and Interventional Glaucoma Management

(COPE Track) Visionary Approaches: Rethinking Therapeutic and Interventional Glaucoma Management

Rachel Simpson, MD; James Murphy, MD; Mary Qiu, MD; Jessica Steen, OD, FAAO

(COPE Track) Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments

(COPE Track) Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments

David S. Liao, MD, PhD; Chang Sup Lee, MD; Douglas Matsunaga, MD; Daniel Su, MD

(COPE Track) Expanding Horizons in Toric IOLs: Translating Technological Advances Into Improved Patient Outcomes

(COPE Track) Expanding Horizons in Toric IOLs: Translating Technological Advances Into Improved Patient Outcomes

Rahul Tonk, MD, MBA

(COPE Track) The TED Perspective: A Multidisciplinary Approach to Thyroid Eye Care

(COPE Track) The TED Perspective: A Multidisciplinary Approach to Thyroid Eye Care

Sara T. Wester, MD, FACS; Cecelia Koetting, OD; Sophie Liao, MD; Jennifer Murdock, MD

$(COPE Track) The Neural Frontier: Mapping Neurostimulation Across the DED Patient Spectrum for Refractive Surgery$

(COPE Track) The Neural Frontier: Mapping Neurostimulation Across the DED Patient Spectrum for Refractive Surgery

Zeba A. Syed, MD

(COPE Track) Patient-Centered Treatment Strategies in the Management of nAMD and DME

(COPE Track) Patient-Centered Treatment Strategies in the Management of nAMD and DME

Adrienne W. Scott, MD, FASRS; Justine Cheng, MD; Hong-Uyen Hua, MD; Sherrol A. Reynolds OD, FAAO, FNAP

$(CME Track) The Neural Frontier: Mapping Neurostimulation Across the DED Patient Spectrum for Refractive Surgery$

(CME Track) The Neural Frontier: Mapping Neurostimulation Across the DED Patient Spectrum for Refractive Surgery

Zeba A. Syed, MD

(COPE Credit) Time Matters in GA: The Impact of Early Detection and Proactive Treatment Approaches

(COPE Credit) Time Matters in GA: The Impact of Early Detection and Proactive Treatment Approaches

Laxmi V. Devisetty, MD; Rodney P. Coe, MD, MS; Majda Hadziahmetovic, MD; Xiao Yi (Ellie) Zhou, MD

20th Annual Controversies in Modern Eye Care

In-Person Event

20th Annual Controversies in Modern Eye Care

April 19, 2026

(COPE Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

(COPE Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Yasha Modi, MD; Carolyn Majcher, OD, FAAO, FORS

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Yasha Modi, MD; Carolyn Majcher, OD, FAAO, FORS

(COPE Track) Rapid Reviews in Retina™: Emerging Updates from Winter 2025 – Addressing the Wealth of New Data in Treatments for nAMD and DME

(COPE Track) Rapid Reviews in Retina™: Emerging Updates from Winter 2025 – Addressing the Wealth of New Data in Treatments for nAMD and DME

David M. Brown, MD, FACS; Dilraj S. Grewal, MD

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Winter 2025 – Addressing the Wealth of New Data in Treatments for nAMD and DME

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Winter 2025 – Addressing the Wealth of New Data in Treatments for nAMD and DME

David M. Brown, MD, FACS; Dilraj S. Grewal, MD

Living With X-Linked Retinitis Pigmentosa: What We Can Learn From a Patient’s Experience

Living With X-Linked Retinitis Pigmentosa: What We Can Learn From a Patient’s Experience

Lejla Vajzovic, MD, FASRS; Ramiro Maldonado, MD

(CME Track) Collaborative Community Connections™: Mastering the Management of nAMD and DME Through Therapeutic Innovation

(CME Track) Collaborative Community Connections™: Mastering the Management of nAMD and DME Through Therapeutic Innovation

Veeral Sheth, MD, MBA, FASRS, FACS; Mark R. Barakat, MD, FASRS; Geeta Lalwani, MD; Xiao Yi Zhou, MD

Living With X-Linked Retinitis Pigmentosa: What We Can Learn From a Patient’s Experience

Living With X-Linked Retinitis Pigmentosa: What We Can Learn From a Patient’s Experience

Lejla Vajzovic, MD, FASRS; Ramiro Maldonado, MD

(COPE Track) Collaborative Community Connections™: Mastering the Management of nAMD and DME Through Therapeutic Innovation

(COPE Track) Collaborative Community Connections™: Mastering the Management of nAMD and DME Through Therapeutic Innovation

Veeral Sheth, MD, MBA, FASRS, FACS; Mark R. Barakat, MD, FASRS; Geeta Lalwani, MD; Xiao Yi Zhou, MD

Collaborative Care Symposium

Collaborative Care Symposium

May 2-3, 2026

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

Navigating the Glaucoma Therapeutic and Surgical Landscape: From Conventional to Cutting-Edge

Deborah Ristvedt, DO; Melissa Tawa, OD, FAAO

(CME Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

(CME Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Melissa Barnett, OD, FAAO, FSLS, FBCLA; Cecelia Koetting, OD, FAAO, DipABO; Quan Đông Nguyễn, MD, MSc; Jennifer Li, MD

(COPE Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

(COPE Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Melissa Barnett, OD, FAAO, FSLS, FBCLA; Cecelia Koetting, OD, FAAO, DipABO; Quan Đông Nguyễn, MD, MSc; Jennifer Li, MD

(CME Track) The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

(CME Track) The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

Marjan Farid, MD; John Hovanesian, MD; Beeran Meghpara, MD

(COPE Track) The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

(COPE Track) The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

Marjan Farid, MD; John Hovanesian, MD; Beeran Meghpara, MD

(CME Track) Toric IOLs Unleashed: From Technological Progress to Patient Success

(CME Track) Toric IOLs Unleashed: From Technological Progress to Patient Success

Tanner Ferguson, MD; Taj Nasser, MD, FWCRS

(CME Track) Clinical Case Connections: Understanding the Impact of Advances in Treatment for DME and DR

(CME Track) Clinical Case Connections: Understanding the Impact of Advances in Treatment for DME and DR

David A. Eichenbaum, MD

(COPE Track) Clinical Case Connections: Understanding the Impact of Advances in Treatment for DME and DR

(COPE Track) Clinical Case Connections: Understanding the Impact of Advances in Treatment for DME and DR

David A. Eichenbaum, MD

(COPE Track) Clinical Case Connections: Expert Insights on Applying Therapeutic Innovations in nAMD

(COPE Track) Clinical Case Connections: Expert Insights on Applying Therapeutic Innovations in nAMD

Nathan C. Steinle, MD

(CME Track) Clinical Case Connections: Expert Insights on Applying Therapeutic Innovations in nAMD

(CME Track) Clinical Case Connections: Expert Insights on Applying Therapeutic Innovations in nAMD

Nathan C. Steinle, MD

(COPE Track) Toric IOLs Unleashed: From Technological Progress to Patient Success

(COPE Track) Toric IOLs Unleashed: From Technological Progress to Patient Success

Tanner Ferguson, MD; Taj Nasser, MD, FWCRS

(COPE Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

(COPE Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

Jacob Lang, OD, FAAO; Selina R. McGee, OD, FAAO; Neda Shamie, MD

(CME Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

(CME Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

Jacob Lang, OD, FAAO; Selina R. McGee, OD, FAAO; Neda Shamie, MD

Neurotrophic Keratitis Insights: An Interactive Corneal Sensitivity Testing Workshop

Neurotrophic Keratitis Insights: An Interactive Corneal Sensitivity Testing Workshop

John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; John Hovanesian, MD, FACS

(COPE Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

(COPE Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

Arjan Hura, MD; Neda Shamie, MD; Kristin Barnes, OD

(CME Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

(CME Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

Arjan Hura, MD; Neda Shamie, MD; Kristin Barnes, OD

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

SriniVas Sadda, MD, FARVO; Nathan Steinle, MD

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Mark Schaeffer, OD, FAAO; Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO, FAAOMS; Selina R. McGee, OD, FAAO

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

All News

Glaucoma 2026: Which emerging technologies will change practice?

ByJoel S. Schuman, MD, FACS,Sheryl Stevenson

December 26th 2025

From artificial intelligence to home monitoring, Joel Schuman, MD, of Wills Eye Hospital, explores the innovations that could change how clinicians detect and treat glaucoma in the new year.

(Image credit: AdobeStock/ABDULELLAH) AI in ophthalmology research: Ethical implications for medical students

AI in ophthalmology research: Ethical implications for medical students

ByRohini Chahal, BSA,Nicole Koulov, BS,Sophie Saland, BA,Amna Ali, BA,Andrew G. Lee, MD

December 23rd 2025

As artificial intelligence tools become more common in research, students must navigate issues including plagiarism, data consent, and equitable application.

How AI is reshaping ophthalmology in 2025 and beyond

ByLynda Charters

December 23rd 2025

Reimagining dry eye care: Focus on sustained tear production

ByLynda Charters

December 23rd 2025

Panel examines drug mechanisms, patient factors, and strategies to optimize results.

8 Things to Know About Aflibercept 8 mg for Retinal Vascular Disease

8 things to know about aflibercept 8 mg for retinal vascular disease

ByOphthalmology Times Staff Reports

December 22nd 2025

A trio of retina specialists recently reviewed the clinical benefits of aflibercept 8 mg, including its extended dosing intervals, improved patient satisfaction, and enhanced treatment outcomes for various conditions.

From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases

By Siegfried G. Priglinger

December 22nd 2025

(Image credit: AdobeStock/Pixel-Shot) Topical liposomal ozonated oil may be a useful treatment in neurotrophic keratopathy

Topical liposomal ozonated oil may be a useful treatment in neurotrophic keratopathy

December 20th 2025

Alternative management may avoid current concerns found with antibiotics.

The Atrophy Advisor: An online tool to inform GA treatment decisions

ByLynda Charters

December 19th 2025

Screening for Demodex blepharitis: Integrating best practices into routine eye care

ByLynda Charters

December 19th 2025

Dompé enrolls first patients in phase 3 study of isocyclosporin for treatment of atopic keratoconjunctivitis

December 18th 2025

Seeing the difference: Multimodal imaging for AMD and GA

ByJeremiah Brown Jr, MD, MS, FASRS

December 18th 2025

This approach helps distinguish diseases associated with macular atrophy.

NCX 470 advances toward US, China NDA submissions for NCX 470

ByMartin David Harp

December 17th 2025

NCX 470 is Nicox’s lead dual-mechanism bimatoprost eye drop for lowering IOP in open-angle glaucoma or ocular hypertension.

Malar edema: Perspectives from plastic surgery and ophthalmology

ByKay Durairaj, MD, FACS,Julie Anush Kazaryan, BS

December 17th 2025

Insights for diagnosing and managing these visible changes across specialties.

Spotlight on women's health: Understanding thyroid eye disease

ByLynda Charters

December 17th 2025

FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report

ByMartin David Harp

December 16th 2025

Aldeyra met with the FDA on December 12, 2025, in which the FDA requested the company submit the CSR from the reproxalap dry eye disease field trial to the NDA.

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

How AI is reshaping ophthalmology in 2025 and beyond

Glaucoma 2026: Which emerging technologies will change practice?

8 things to know about aflibercept 8 mg for retinal vascular disease

The year in optometry: 10 stories that defined eye care in 2025

Molecular insights and clinical experience: Extending anti-VEGF durability